SE462849B - Hydantoinderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma - Google Patents

Hydantoinderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma

Info

Publication number
SE462849B
SE462849B SE8500387A SE8500387A SE462849B SE 462849 B SE462849 B SE 462849B SE 8500387 A SE8500387 A SE 8500387A SE 8500387 A SE8500387 A SE 8500387A SE 462849 B SE462849 B SE 462849B
Authority
SE
Sweden
Prior art keywords
group
formula
spiro
dimethyl
compound
Prior art date
Application number
SE8500387A
Other languages
English (en)
Swedish (sv)
Other versions
SE8500387L (sv
SE8500387D0 (sv
Inventor
N Minami
M Mathukura
K Ueda
S Tanaka
T Igarashi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE8500387D0 publication Critical patent/SE8500387D0/xx
Publication of SE8500387L publication Critical patent/SE8500387L/xx
Publication of SE462849B publication Critical patent/SE462849B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE8500387A 1984-01-30 1985-01-28 Hydantoinderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma SE462849B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59013442A JPS60158190A (ja) 1984-01-30 1984-01-30 ヒダントイン誘導体およびその製法ならびにそれを含有する医薬

Publications (3)

Publication Number Publication Date
SE8500387D0 SE8500387D0 (sv) 1985-01-28
SE8500387L SE8500387L (sv) 1985-07-31
SE462849B true SE462849B (sv) 1990-09-10

Family

ID=11833246

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8500387A SE462849B (sv) 1984-01-30 1985-01-28 Hydantoinderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma

Country Status (23)

Country Link
US (1) US4650798A (ko)
JP (1) JPS60158190A (ko)
KR (1) KR870001681B1 (ko)
AU (1) AU585207B2 (ko)
BE (1) BE901591A (ko)
CA (1) CA1249271A (ko)
CH (1) CH662354A5 (ko)
DE (1) DE3503074A1 (ko)
DK (1) DK158668C (ko)
ES (2) ES8605523A1 (ko)
FI (1) FI83873C (ko)
FR (1) FR2558835B1 (ko)
GB (1) GB2155466B (ko)
HU (1) HU194885B (ko)
IE (1) IE850136L (ko)
IT (1) IT1184144B (ko)
MX (1) MX160579A (ko)
NL (1) NL8500248A (ko)
NZ (1) NZ210979A (ko)
PH (1) PH21920A (ko)
SE (1) SE462849B (ko)
SU (3) SU1468424A3 (ko)
ZA (1) ZA85655B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2708507B2 (ja) * 1988-04-07 1998-02-04 株式会社三和化学研究所 （ｄ）‐６‐フルオロ‐２，３‐ジヒドロ‐２’，５’‐ジオキソ‐スピロ［４Ｈ‐１‐ベンゾピラン‐４，４’‐イミダゾリジン］‐２‐カルボキサミド誘導体、これらの製法及び用途
EP0347733A1 (en) * 1988-06-20 1989-12-27 Eisai Co., Ltd. Optically active hydantoin derivatives
IL96507A0 (en) * 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
US5206240A (en) * 1989-12-08 1993-04-27 Merck & Co., Inc. Nitrogen-containing spirocycles
US5382587A (en) * 1993-06-30 1995-01-17 Merck & Co., Inc. Spirocycles
US5403846A (en) * 1993-11-22 1995-04-04 Merck & Co., Inc. Spirocycles
US5439914A (en) * 1994-02-18 1995-08-08 Merck & Co., Inc. Spirocycles
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament

Also Published As

Publication number Publication date
DE3503074A1 (de) 1985-08-08
KR870001681B1 (ko) 1987-09-22
FR2558835B1 (fr) 1990-05-18
FI83873C (fi) 1991-09-10
JPH0441149B2 (ko) 1992-07-07
ES8606293A1 (es) 1986-04-16
FI83873B (fi) 1991-05-31
HU194885B (en) 1988-03-28
NZ210979A (en) 1987-05-29
SU1445559A3 (ru) 1988-12-15
DK158668B (da) 1990-07-02
DK39585D0 (da) 1985-01-29
ES548960A0 (es) 1986-04-16
KR850005442A (ko) 1985-08-26
ES8605523A1 (es) 1986-03-16
SE8500387L (sv) 1985-07-31
CA1249271A (en) 1989-01-24
SU1468424A3 (ru) 1989-03-23
FI850302A0 (fi) 1985-01-23
BE901591A (fr) 1985-07-29
FR2558835A1 (fr) 1985-08-02
GB2155466B (en) 1987-10-07
PH21920A (en) 1988-04-08
IE850136L (en) 1985-07-30
FI850302L (fi) 1985-07-31
CH662354A5 (fr) 1987-09-30
DK39585A (da) 1985-07-31
IT8519296A0 (it) 1985-01-30
US4650798A (en) 1987-03-17
AU585207B2 (en) 1989-06-15
DK158668C (da) 1990-11-26
JPS60158190A (ja) 1985-08-19
GB2155466A (en) 1985-09-25
ES539942A0 (es) 1986-03-16
GB8502308D0 (en) 1985-02-27
SU1609453A3 (ru) 1990-11-23
SE8500387D0 (sv) 1985-01-28
MX160579A (es) 1990-03-27
AU3806285A (en) 1985-08-08
ZA85655B (en) 1985-08-28
IT1184144B (it) 1987-10-22
NL8500248A (nl) 1985-08-16
HUT38646A (en) 1986-06-30

Similar Documents

Publication Publication Date Title
EP0625507B1 (en) Urea derivatives and their use as acat inhibitors
EP0563345B1 (en) Novel 4-arylpiperazines and 4-arylpiperidines
US4129565A (en) Isocarbostyril derivatives
SU508200A3 (ru) Способ получени производных морфолина
EP0029707B1 (en) Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
EP1368313B1 (de) Verfahren zur herstellung von nicht hydratisiertem fexofenadin-hydrochlorid in form eines neuen polymorphs
SE462849B (sv) Hydantoinderivat, foerfarande foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma
EP0000220A1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
CA1053230A (en) 4-arylpiperidine derivatives and processes for the production thereof
US4213984A (en) 11-(Piperazino-acetyl)-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-ones and salts thereof
EP0297380B1 (de) Indolylpropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltende Zubereitungen
AU594840B2 (en) 1-aryloxy-3-amino-2-propanols
US3954776A (en) 1-[Methylated piperidino(and pyrrolidin-1-yl)]-3-(substituted phenoxy)-2propanols
EP0352639B1 (de) p-Hydroxiphenon-Derivate und deren Anwendung
US2802003A (en) Derivatives of 3-azabicycloheptane
DE2430454A1 (de) Neue pyrazolo eckige klammer auf 3,4d eckige klammer zu pyrimidine
SK77494A3 (en) Piperidines and piperazines
DE3703633A1 (de) Purin-derivate, ihre herstellung und sie enthaltende arzneimittel
US4792553A (en) Diene derivatives and vasodilators containing the same
EP0481288B1 (de) 1-Phenylpiperid-4-ylamine und diese enthaltende Arzneimittel
US5422353A (en) Tetrahydropyridine derivatives
US4260623A (en) Hexahydro-1-arylspiro(3H-oxazolo(3,4-A)pyridine-3,4'-piperidene) antidepressants, pharmaceutical compositions thereof and method of use thereof
HU176754B (en) Process for producing new substituted n-square bracket-1-bracket-3,4-methylenedioxy-phenyl-bracket closed-propyl-2-square bracket closed-n-comma above-bracket-substituted-phenyl-bracket closed-piperasines
EP0352640B1 (de) p-Hydroxiphenon-Derivate und diese enthaltende Arzneimittel
US3356681A (en) Xanthenylpiperazine anti-depressants

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8500387-9

Effective date: 19920806

Format of ref document f/p: F